SCHEMBL1355678

SCHEMBL1355678

COc1cccc(-n2ncc3cnc(Nc4ccc5c(c4)OCO5)nc32)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 1/20 0.48
TUBB P07437 1/20 0.48
TUBA3C P0DPH7 1/20 0.48
TUBA1B P68363 1/20 0.48
TUBA4A P68366 1/20 0.48
TUBB4B P68371 1/20 0.48
TUBB3 Q13509 1/20 0.48
TUBB2A Q13885 1/20 0.48
TUBB8 Q3ZCM7 1/20 0.48
TUBA3E Q6PEY2 1/20 0.48
TUBA1A Q71U36 1/20 0.48
TUBA1C Q9BQE3 1/20 0.48
TUBB6 Q9BUF5 1/20 0.48
TUBB2B Q9BVA1 1/20 0.48
TUBB1 Q9H4B7 1/20 0.48
LMNA P02545 2/20 0.48
PTGS2 P35354 1/20 0.48
EIF2AK4 Q9P2K8 1/20 0.48
MAPT P10636 4/20 0.47
ULK1 O75385 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1356713 0.92 MAPT (0.51) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL1355784 0.84 EIF2AK4 (0.59) LMNAEIF2AK4MAPTGAANPSR1
SCHEMBL1356097 0.83 MAPT (0.52) LMNAEIF2AK4MAPTHTTNPSR1
SCHEMBL1356669 0.83 EIF2AK4 (0.57) LMNAEIF2AK4MAPTULK1GAA
SCHEMBL1355806 0.82 EIF2AK4 (0.56) LMNAEIF2AK4MAPTGAANPSR1
SCHEMBL1353591 0.82 EIF2AK4 (0.56) LMNAEIF2AK4MAPTGAANPSR1
SCHEMBL1355529 0.82 EIF2AK4 (0.53) EIF2AK4MAPTNPSR1AURKACDK4
SCHEMBL1355283 0.81 EIF2AK4 (0.52) LMNAEIF2AK4MAPTNPSR1AURKA
SCHEMBL1355852 0.81 FGFR4 (0.63) EIF2AK4AURKACDK4NPC1RAB9A
SCHEMBL1353652 0.80 CDK4 (0.54) EIF2AK4MAPTHTTNPSR1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281821-A9 Modulators of Mitotic Kinases BIOGEN IDEC MA INC. (US) 2011-11-17 US claimed
US-20100249067-A1 Modulators of Mitotic Kinases BIOGEN IDEC MA INC. (US) 2010-09-30 US claimed
EP-2108020-A2 1-H-PYRAZOLO[3,4B]PYRIMIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF MITOTIC KINASES Biogen Idec MA, Inc. (US) 2009-10-14 EP claimed
WO-2008094602-A2 1-H-PYRAZOLO (3,4B) PYRIMIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF MITOTIC KINASES BIOGEN IDEC MA INC. (US) 2008-08-07 WO claimed
US-20110281821-A9 Modulators of Mitotic Kinases BIOGEN IDEC MA INC. (US) 2011-11-17 US disclosed
US-20100249067-A1 Modulators of Mitotic Kinases BIOGEN IDEC MA INC. (US) 2010-09-30 US disclosed
EP-2108020-A2 1-H-PYRAZOLO[3,4B]PYRIMIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF MITOTIC KINASES Biogen Idec MA, Inc. (US) 2009-10-14 EP disclosed
WO-2008094602-A2 1-H-PYRAZOLO (3,4B) PYRIMIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF MITOTIC KINASES BIOGEN IDEC MA INC. (US) 2008-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249067-A1 Modulators of Mitotic Kinases BUB1, BUB1B, CDK1 TUBB4A 537/4885TUBB 387/4885TUBA3C 769/4885
US-20110281821-A9 Modulators of Mitotic Kinases BUB1, BUB1B, CDK1 TUBB4A 537/4885TUBB 387/4885TUBA3C 769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.